Welcome to our dedicated page for Carecloud news (Ticker: CCLD), a resource for investors and traders seeking the latest updates and insights on Carecloud stock.
CareCloud, Inc. reports developments in AI-powered healthcare technology and revenue cycle management for medical practices and health systems. Company updates center on electronic health records, practice management, medical billing, patient experience management, business intelligence, digital health, and AI product portfolios including stratusAI, cirrusAI, and Marketware.
Recurring news themes include quarterly results, guidance, customer selections, product expansion into inpatient EHR, RCM, and analytics, and capital-structure actions involving credit facilities and preferred-stock matters. Updates also address cross-sell strategy, automation initiatives, conference presentations, and operational performance across its Healthcare IT and Medical Practice Management activities.
CareCloud (Nasdaq: CCLD) reaffirmed its previously issued financial guidance after completing a capital structure simplification on April 16, 2026.
Key actions include closing a $50 million credit facility and redeeming 100% of Series B preferred stock. The company reports ~$130 million revenue and ~$30 million annualized adjusted EBITDA, citing improved financial flexibility and institutional support for its next growth phase.
CareCloud (Nasdaq: CCLD, CCLDO) closed a $50 million credit facility on April 13, 2026, with Citizens Bank and Provident Bank and will fully redeem 100% of its outstanding 8.75% Series B preferred stock on May 15, 2026.
The redemption covers 1,511,372 shares at a Total Redemption Price of $27.52 per share, eliminates roughly $3.2 million in annual preferred dividends, and simplifies the capital structure while preserving non-dilutive institutional financing and liquidity.
CareCloud (Nasdaq: CCLD) announced a new partnership with Arkansas Otolaryngology Center to deploy AI-enabled practice management and revenue cycle management (RCM) solutions across the multi-location ENT practice.
The collaboration will deliver AI-powered claims management, automated denial prevention, coding education, real-time dashboards, and AI-driven financial analytics aimed at accelerating revenue capture and improving clean claim rates, with the company emphasizing reductions in days in accounts receivable and enhanced operational transparency.
CareCloud (Nasdaq: CCLD) will present at the 2026 AAPPR Annual Conference in Orlando, April 13–15, showcasing its Marketware physician strategy platform and a soon-to-launch AI update.
Marketware aims to improve pipeline visibility, accelerate time-to-fill, match clinical candidates to best-fit roles, and measure recruitment ROI. The presentation, “The Right Data, Right Now: Recruitment Reporting That Matters,” will highlight real-time pipeline visibility, actionable workforce strategy, and ROI from recruitment investments.
CareCloud (Nasdaq: CCLD) highlighted the completed Preferred A conversion and progress toward simplifying capital structure. The March 6, 2025 conversion issued ~26 million common shares, raising total common shares from ~16 million to ~42 million. The company reaffirmed prior financial guidance and cited recurring revenue and strong cash flow.
CareCloud noted a recent closing price of $3.49 (March 27, 2026) and said ~3 substantial Preferred A holders remain outstanding; ~ $40 million of Series B preferred remains non-convertible.
CareCloud (Nasdaq: CCLD) is showcasing its enhanced MAP App at the HFMA Revenue Cycle Conference in Arlington, March 19, 2026, demonstrating updates made since acquiring the platform from HFMA.
The company will host a networking happy hour on March 19 and a live webinar on April 7, 2026 at 1:00 PM ET to review product updates, roadmap, and use cases.
CareCloud (Nasdaq: CCLD) will participate in the 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum on March 17, 2026, featuring a company fireside chat streamed live to registered attendees.
CareCloud recently reported full-year 2025 results: its first full year of positive EPS since IPO, exceeded its upsized revenue forecast range, and increased free cash flow by more than 500% over three years. A replay will be available at the company investor relations site.
CareCloud (Nasdaq: CCLD) will ring the Nasdaq Closing Bell on May 19, 2026 and host its 2026 Analyst Day at the Nasdaq MarketSite in New York City. The event will showcase new AI-powered products and a management business update on strategic priorities.
The announcement highlights CareCloud reporting its first full year of positive EPS since its IPO 12 years ago and a roughly 18% rise in its common stock over two trading days after release of full-year 2025 results.
CareCloud (Nasdaq: CCLD) reported full‑year 2025 revenue of $120.5M (+8.7% YoY), GAAP net income of $10.8M (+37.5% YoY) and its first full‑year positive GAAP EPS since its 2014 IPO of $0.10. The company closed acquisitions including Medsphere, entered inpatient software, launched AI products, generated $28.6M cash from operations and repaid its credit line.
Management issued 2026 guidance: $128–$132M revenue, $29–$31M adjusted EBITDA and GAAP EPS of $0.20–$0.23.
CareCloud (Nasdaq: CCLD) will release fourth quarter and full year 2025 financial results before market open on March 12, 2026.
A conference call for investors will follow at 8:30 a.m. ET with a live webcast, audio options, downloadable slides, and a replay available at ir.carecloud.com/events.